ROUTE,

DATE MECHANIS
NAME OF DOSAGE INDICA- CONTRAINDICA- SIDE CLIENT’S NURSING
ADMINIS M OF
DRUG AND FRE- TION TION EFFECTS RESPONSE RESPONSIBILITIES
-TERED ACTION
QUENCY
Generic May 35, Zolpidem 5 Enhances Short-  Hypersensitivity to Occasional The client’s Before Administration:
Name: 2021 mg IVP action ofterm zolpidem. (7%): sleep-rest  Check the doctor’s
 zolpidem PRN for inhibitory treatment  Headache pattern was order.
insomnia at neuro- of Cautions:  Change in improved;  Observe for the 12
Brand Name: HS transmitter insomnia.  Hepatic appetite. he was able rights of drug
 Dormizol gamma- impairment to freely rest administration.
aminobutyric  Patients with Rare (less than and sleep  Assess B/P, pulse,
Classification: acid (GABA). depression 2%): well. respirations, mental
Pharmaco-  History of drug  Dizziness status, sleep patterns.
therapeutic: Therapeutic dependence  Nausea  Raise bed rails, provide
 Hypnotic Effect:  Sleep apnea  Diarrhea call light.
Induces  COPD  Muscle pain  Provide environment
Clinical: sleep with conducive to sleep
 Respiratory disease  Sleepwalking
 Sedative- fewer nightly (back rub, quiet
 Myasthenia gravis
hypnotic awakenings, environment, low
 Debilitated patients
improves sleep lighting).
 Elderly
Pregnancy quality.  Do not give unless a
Category: C full night of sleep is
planned.

During Administration:
 Administer 5 mg via
intravenous push as
needed at hour of
sleep.

After Administration:
 Monitor sleep pattern
of client.
 Evaluate for
therapeutic response to
insomnia:
o Decrease in number
of nocturnal
awakenings.
o Increase in length
of sleep.
 Monitor daytime
alertness, respiratory
rate, behavior profile.

Client/Family
Education:
 Avoid alcohol and
tasks that require
alertness, motor skills
until response to drug
is established.
 Do not take unless a
full 8 hours of sleep is
planned.